跳至主要内容
临床试验/NCT01660841
NCT01660841已完成3 期

A Multicenter, Open-label, Phase III Study to Determine the Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects Referred for Contrast-enhanced MRI of the Central Nervous System (CNS)

Bayer0 个研究点目标入组 223 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Bayer
入组人数
223
主要终点
Scores for visualization parameter: border delineation

研究概览

简要总结

Purpose of the study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking images of the brain and spine. The results of the Magnetic Resonance Imaging (MRI) will be compared to the results of images taken without contrast (gadobutrol).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects referred for a contrast-enhanced Magnetic Resonance Imaging (MRI) of the central nervous system based on current clinical symptoms or results of a previous imaging procedure

排除标准

  • Subjects with any contraindication to the MRI examination
  • Subjects with severe renal disease to end stage renal disease
  • Subjects scheduled or are likely to require a biopsy or any interventional therapeutic procedure within 72 (±4) hours after the study MRI

研究组 & 干预措施

Arm 1

Experimental

干预措施: Gadobutrol (Gadovist, BAY86-4875) (Drug)

结局指标

主要结局

Scores for visualization parameter: border delineation

时间窗: Day of gadobutrol injection (Day 0)

Blinded readers evaluate border delineation of at maximum 5 lesions and 4 normal brain structures in scans taken with and without injection of gadobutrol on a 4-point-scale.

Scores for visualization parameter: internal morphology

时间窗: Day of gadobutrol injection (Day 0)

Blinded readers evaluate internal morphology of at maximum 5 lesions and 4 normal structures in scans taken with and without gadobutrol on a 3-point-scale.

Scores for visualization parameter: degree of contrast enhancement

时间窗: Day of gadobutrol injection (Day 0)

Blinded readers evaluate contrast of at maximum 5 lesions and 4 normal brain structures in scans taken with and without injection of gadobutrol on a 4-point-scale.

Number of detected lesions

时间窗: Day of gadobutrol injection (Day 0)

Blinded readers determine number of detected lesions in scans with and without gadobutrol.

次要结局

  • Percentage of exact match of the MRI diagnosis with the final clinical diagnosis(Day of gadobutrol injection (Day 0))
  • Sensitivity and specificity to detect abnormal/normal brain tissue(Day of gadobutrol injection (Day 0))
  • Number of participants with treatment emergent adverse events as a measure of safety and tolerability(3 days after injection (Day 3))
  • Sensitivity and specificity to detect malignant Central Nervous System(CNS) lesions(Day of gadobutrol injection (Day 0))

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验